A carregar...
Ranibizumab treatment history as predictor of the switch-response to aflibercept: evidence for drug tolerance
PURPOSE: To investigate whether tolerance to the anti-VEGF drug, ranibizumab, develops after drug exposure and to determine whether the history of treatment with ranibizumab prior to refractoriness can predict the post-switching responses to aflibercept. METHODS: We retrospectively investigated neov...
Na minha lista:
| Publicado no: | Clin Ophthalmol |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove Medical Press
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5880512/ https://ncbi.nlm.nih.gov/pubmed/29636594 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OPTH.S160367 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|